抄録
The corresponding author recently notified the JCI that the patient data presented in Figure 1B were not correct. Analysis of the correct patient data set does not show a significant difference in CERS6expression in human lung adenocarcinomas with positive invasive growth (definite) compared with those with negligible invasive growth or without invasive growth (focal/none). The Editors have requested an institutional investigation into this matter, and we will inform our readers of the outcome when the investigation is complete.
| 本文言語 | 英語 |
|---|---|
| ページ(範囲) | 3464 |
| ページ数 | 1 |
| ジャーナル | Journal of Clinical Investigation |
| 巻 | 129 |
| 号 | 8 |
| DOI |
|
| 出版ステータス | 出版済み - 01-08-2019 |
UN SDG
この成果は、次の持続可能な開発目標に貢献しています
-
SDG 3 すべての人に健康と福祉を
All Science Journal Classification (ASJC) codes
- 医学一般
フィンガープリント
「Erratum: Targeting ceramide synthase 6–dependent metastasis-prone phenotype in lung cancer cells Citation for this expression of concern (Journal of Clinical Investigation (2019) 129:8 (3464) Doi:10.1172/JCI131245)」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。引用スタイル
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver